Results 21 to 30 of about 39,968 (304)
Dynamic Insulin Basal Needs Estimation and Parameters Adjustment in Type 1 Diabetes
Sensors, 2021 Technology advances have made possible improvements such as Continuous Glucose Monitors, giving the patient a glucose reading every few minutes, or insulin pumps, allowing more personalized therapies.
Jesús Berián +4 more
doaj +1 more source
Mast Cell Deficiency in Mice Attenuates Insulin Phenolic Preservative-Induced Inflammation
Biomedicines, 2023 One major obstacle that limits the lifespan of insulin infusion pumps is surmounting the tissue site reaction at the device implantation site. All commercial insulin formulations contain insulin phenolic preservatives (IPPs) designed to ensure insulin ...
Shereen Kesserwan +3 more
doaj +1 more source
Endocrinology Research and Practice, 2015 Diabetes mellitus (DM) is an important health problem that should be treated efficiently because of its high prevalence and high morbidity and mortality due to its complications.
Soner Cander +2 more
doaj +1 more source
Real-World Analysis of Therapeutic Outcome in Type 1 Diabetes Mellitus at a Tertiary Care Center [PDF]
Diabetes & Metabolism Journal, 2022 Insulin replacement in type 1 diabetes mellitus (T1DM) needs intensified treatment, which can either be performed by multiple daily injections (MDI) or continuous subcutaneous insulin infusion (CSII).
Antonia Kietaibl +2 more
doaj +1 more source
Frontiers in Pediatrics, 2021 The goal in type 1 diabetes (T1D) therapy is to maintain optimal glycemic control under any circumstance. Diabetes technology is in continuous development to achieve this goal. The most advanced Food and Drug Administration- and European Medicines Agency-
Jesus Dominguez-Riscart +9 more
doaj +1 more source
Transient Neonatal Diabetes Mellitus Managed with Continuous Subcutaneous Insulin Infusion (CSII) and Continuous Glucose Monitoring [PDF]
Neonatal Medicine, 2021 Neonatal diabetes mellitus can be categorized as transient, permanent, or syndromic, and approximately half of the cases are transient. We present a case involving a term newborn who showed overt progression of transient neonatal diabetes mellitus, with ...
Min Soo Kim +9 more
doaj +1 more source
Use of Sensors in the Treatment and Follow-up of Patients with Diabetes Mellitus
Sensors, 2010 Glucose control is the cornerstone of Diabetes Mellitus (DM) treatment. Although self-regulation using capillary glycemia (SRCG) still remains the best procedure in clinical practice, continuous glucose monitoring systems (CGM) offer the possibility of ...
Manuel Aguilar-Diosdado +4 more
doaj +1 more source
Current Advances of Artificial Pancreas Systems: A Comprehensive Review of the Clinical Evidence [PDF]
Diabetes & Metabolism Journal, 2021 Since Banting and Best isolated insulin in the 1920s, dramatic progress has been made in the treatment of type 1 diabetes mellitus (T1DM). However, dose titration and timely injection to maintain optimal glycemic control are often challenging for T1DM ...
Sun Joon Moon +2 more
doaj +1 more source
An overview on recent developments in insulin pump therapy with a regional perspective [PDF]
Journal of Research in Clinical MedicineInsulin therapy is vital for managing elevated glucose levels among patients with type 1 diabetes and some individuals with type 2 diabetes. A drawback in traditional methods of insulin administration, including syringes and pens, lies in their limited ...
Faatimah Maryam Muzammil +5 more
doaj +1 more source
Biomédica: revista del Instituto Nacional de Salud, 2019 Introduction: The non-interventional International Operations Hypoglycemia Assessment Tool (IO-HAT) study assessed the incidence of hypoglycemia in patients with insulin-treated diabetes across nine countries, including a cohort of patients in Colombia ...
Ana María Gómez +6 more
doaj +1 more source